TY  - CONF

T1  - 337 Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis

JO  - British Journal of Dermatology

UR  - http://dx.doi.org/10.1093/bjd/ljac140.031

PY  - 2023/01/25

AU  - Siegfried EC

AU  - Cork MJ

AU  - Arkwright PD

AU  - Wollenberg A

AU  - Eichenfield LF

AU  - Ramien M

AU  - Khokhar FA

AU  - Chen Z

AU  - Zhang A

AU  - Cyr SL

ED  - 

DO  - DOI: 10.1093/bjd/ljac140.031

PB  - Oxford University Press (OUP)

VL  - 188

IS  - Supplement_2

Y2  - 2024/12/22

ER  -